1. Potential antitumour agents. 50. In vivo solid tumour activity of derivatives of N-[2-(dimethylamino)ethylacridine-4-carboxamide;Atwell;J Med Chem,1987
2. Selectivity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro;Finlay;Eur J Cancer Clin Oncol,1989
3. Robertson IGC, Palmer BD, Paxton JW and Bland TJ, Metabolism of the experimental antitumour agent acridine carboxamide (AC) in the mouse. Drug Metab Dispos, in press.
4. Schlemper B, Paxton JW, Siegers DJ and Robertson IGC, Rat hepatocyte-mediated metabolism of the experimental antitumour agent N-[2'-(dimethylamino)ethyl] acridine-4-carboxamide. Xenobiotica, in press.
5. Inhibitors of cytochrome P-450s and their mechanism of action;Testa;Drug Metab Rev,1981